gvtcx

Scoping of the evaluation approach for the proposed Yellow Card Biobank

Medicines and Healthcare Products Regulatory Agency (MHRA) Published 24 Mar 2022 Contracts Finder

key details

Value£10,000
Statuscomplete
Category (CPV) 79410000
RegionEast of England, London
Deadline17 Feb 2022
Contract start23 Mar 2022
Contract end15 Apr 2022
Proceduredirect
SME suitableYes
OCIDocds-b5fd17-16b173f2-65f1-4714-9192-3d3d0a6ef5c1

Award

SupplierValueDateStatus
RAND Europe Community Interest Company £9,992 10 Mar 2022 active

description

The Medicines and Healthcare products Regulatory Agency (the MHRA) requires services to support in the development of an evaluation strategy at the initial scoping stage of the Yellow Card Biobank project.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
24 Mar 2022 Award (award) · 0b291e2a-50c0-4c4b-807f-a0ee3eef2130-521297

more from Medicines and Healthcare Products Regulatory Agency (MHRA)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.